CorMedix Inc (CRMD NASDAQ) stock market data APIs
$11.4489
-0.26(-2.3%)
as of November 3, 2025
Try our APIs with
free plan!
CorMedix Inc Financial Data Overview
Price chart is built with
Anychart
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
Prev. Close
11.4489
Open
11.1842
High
11.5377
Low
10.7779
52 wk Range
5.6-17.43
Market Cap
904 M
P/E Ratio
14.7949
Shares Outstanding
78 349 K
Revenue
121 M
Beta
1.851
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with CorMedix Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get CorMedix Inc data using free add-ons & libraries
Get CorMedix Inc Fundamental Data
CorMedix Inc Fundamental data includes:
- Net Revenue: 121 M
- EBITDA: 49 853 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-10-28
- EPS/Forecast: 0.2233
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
CorMedix Inc News
New
CRMD vs. TBPH: Which Small-Cap Biotech Stock Is the Better Buy?
In the competitive world of small-cap biotechnology, CorMedix CRMD and Theravance Biopharma TBPH stand out as two companies working to turn scientific progress into lasting profits. Both companies, ha...
MRK Beats Q3 Earnings Estimates, Narrows 2025 Sales View, Stock Down
Merck MRK reported third-quarter 2025 adjusted earnings per share (EPS) of $2.58, which beat the Zacks Consensus Estimate of $2.36. Earnings increased 64% year over year on a reported basis and 65% ex...
Amarin's Q3 Earnings Lag Estimates, Revenues Beat, Stock Down
Amarin Corporation AMRN reported adjusted earnings of 1 cent per share for the third quarter of 2025, which missed the Zacks Consensus Estimate of 8 cents per share. The company had reported an adjust...
United Therapeutics Q3 Earnings Beat Estimates, Revenues Miss Mark
United Therapeutics UTHR reported third-quarter 2025 earnings of $7.16 per share, which beat the Zacks Consensus Estimate of $6.89. Earnings rose 12% year over year on the back of higher product sales...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
